H.R. 6238House119th Congress (2025-2027)Passed House

NIH IMPROVE Act

Introduced November 20, 2025

AI-Generated Summary

Updated July 23, 2026 at 1:12 AM UTC

The NIH IMPROVE Act creates a new NIH program called the IMPROVE Initiative to focus on improving maternal health and pregnancy outcomes in the United States. The initiative directs NIH to fund research and community projects that aim to lower preventable maternal deaths and severe complications, especially among groups with higher rates of these outcomes. It provides up to $63.4 million each year from FY 2026 through FY 2030 to support these efforts.

Key Provisions

  • NIH Director is tasked with running the IMPROVE Initiative to advance research that reduces preventable maternal mortality and severe morbidity.
  • The initiative targets health disparities by supporting studies on biological, behavioral, and other factors affecting maternal outcomes, and by funding community‑based interventions for high‑risk populations.
  • NIH may use grants, contracts, cooperative agreements, or other transactions to carry out the program.
  • An annual appropriation of $63.4 million is authorized for the initiative for fiscal years 2026‑2030.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

12 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

July 21, 2026

View full timeline
HouseIntro Referral

Introduced in House

November 20, 2025

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

November 20, 2025

HouseCommittee

Committee Consideration and Mark-up Session Held

May 21, 2026

HouseCommittee

Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.

May 21, 2026

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-734.

July 9, 2026

HouseCalendars

Placed on the Union Calendar, Calendar No. 638.

July 9, 2026

HouseFloor

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

July 20, 2026 • 4:04 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H4651-4652)

July 20, 2026 • 4:04 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 6238.

July 20, 2026 • 4:04 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4651)

July 20, 2026 • 4:12 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4651)

July 20, 2026 • 4:12 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

July 20, 2026 • 4:12 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

July 21, 2026

Floor Debate

5 members

What members said about H.R. 6238 on the floor

2 Republicans3 Democrats
Alma S. Adams
Rep. Alma S. AdamsD-NC-12 · Jul 20, 2026

Mr. Speaker, I rise to speak in favor of the NIH IMPROVE Act. One of my core beliefs that has led to my work in Congress is that health care is our most basic human right. Yet, in our country, we see…

Lauren Underwood
Rep. Lauren UnderwoodD-IL-14 · Jul 20, 2026

Mr. Speaker, I rise today in support of my bill, the NIH IMPROVE Act. This bipartisan bill, co-led by Congressman Fitzpatrick, will provide consistent funding for research on maternal mortality. The…

Diana DeGette
Rep. Diana DeGetteD-CO-1 · Jul 20, 2026

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, shockingly, the U.S. has the highest rate of maternal mortality among developed nations in this entire world. What is worse is…

Brett Guthrie
Rep. Brett GuthrieR-KY-2 · Jul 20, 2026

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 6238) to establish the IMPROVE Initiative within the National Institutes of Health, as amended. Mr. Speaker, I ask unanimous consent…

Brian K. Fitzpatrick
Rep. Brian K. FitzpatrickR-PA-1 · Jul 20, 2026

Mr. Speaker, I rise today in strong support of our legislation, H.R. 6238, the NIH IMPROVE Act. Mr. Speaker, this critical legislation will ensure consistent funding for research on maternal care and…

Bill Text

4 versions available

Reading Mode
Latest
Referred in SenateIssued July 21, 2026

IIB

119th CONGRESS

2d Session

H. R. 6238

IN THE SENATE OF THE UNITED STATES

July 21, 2026

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To establish the IMPROVE Initiative within the National Institutes of Health.

1.

Short title

This Act may be cited as the NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone Act or the NIH IMPROVE Act.

2.

IMPROVE Initiative

Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following:

409K.

IMPROVE initiative

(a)

In general

The Director of NIH shall continue to carry out a program to improve maternal health outcomes, to be known as the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone Initiative or the IMPROVE Initiative (referred to in this section as the Initiative).

(b)

Objectives

The Initiative shall—

(1)

advance research to—

(A)

reduce preventable causes of maternal mortality and severe maternal morbidity;

(B)

reduce health disparities related to maternal health outcomes, including such disparities associated with populations with disproportionately high rates of maternal mortality and severe maternal morbidity relative to the national rate; and

(C)

improve health for pregnant and postpartum women before, during, and after pregnancy;

(2)

use an integrated approach to understand the factors, including biological, behavioral, and other factors, that affect maternal mortality and severe maternal morbidity by building an evidence base for improved outcomes in specific regions of the United States; and

(3)

target health disparities associated with maternal mortality and severe maternal morbidity by—

(A)

implementing and evaluating community-based interventions for disproportionately affected women; and

(B)

identifying risk factors and the underlying biological mechanisms associated with leading causes of maternal mortality and severe maternal morbidity in the United States.

(c)

Implementation

The Director of NIH may award grants or enter into contracts, cooperative agreements, or other transactions to carry out this section.

(d)

Authorization of appropriations

There is authorized to be appropriated to carry out this section $63,400,000 for each of fiscal years 2026 through 2030.

.

Passed the House of Representatives July 20, 2026.

Kevin F. McCumber,

Clerk.